NCT00351767View on ClinicalTrials.gov

A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers

PHASE2CompletedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2008

Conditions

Foot Ulcer, Diabetic

Interventions

DRUG

placebo

Topically applied

DRUG

telbermin

Topically applied

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY

NCT00351767 - A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter